190 related articles for article (PubMed ID: 37457559)
1. Missing link between tissue specific expressing pattern of ERβ and the clinical manifestations in LGBLEL.
Zhang X; Zhao P; Ma M; Wu H; Liu R; Liu Z; Cai Z; Liu M; Xie F; Ma X
Front Med (Lausanne); 2023; 10():1168977. PubMed ID: 37457559
[TBL] [Abstract][Full Text] [Related]
2. B cell receptor signaling pathway involved in benign lymphoepithelial lesions of the lacrimal gland.
Wang XN; Ge X; Li J; Liu X; Ma JM
Int J Ophthalmol; 2017; 10(5):665-669. PubMed ID: 28546918
[TBL] [Abstract][Full Text] [Related]
3. Different serum levels of IgG and complements and recurrence rates in IgG4-positive and negative lacrimal gland benign lymphoepithelial lesion.
Liu R; Wang N; Wang JJ; Li J; Ge X; Zhang JX; Ma JM
Int J Ophthalmol; 2023; 16(6):876-883. PubMed ID: 37332559
[TBL] [Abstract][Full Text] [Related]
4. The FcεRI signaling pathway is involved in the pathogenesis of lacrimal gland benign lymphoepithelial lesions as shown by transcriptomic analysis.
Li J; Liu R; Sun M; Wang J; Wang N; Zhang X; Ge X; Ma J
Sci Rep; 2021 Nov; 11(1):21853. PubMed ID: 34750466
[TBL] [Abstract][Full Text] [Related]
5. Association analysis of BclI with benign lymphoepithelial lesions of the lacrimal gland and glucocorticoids resistance.
Zhang XJ; Zhao PX; Ma MS; Wu H; Liu R; Wang H; Liu MY; Xie F; Ma XM
Int J Ophthalmol; 2023; 16(11):1734-1745. PubMed ID: 38028530
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Efficacy of Immune and Inflammatory Markers in the Diagnosis of Lacrimal-Gland Benign Lymphoepithelial Lesion.
Luan F; Liu R; Li J; Ge X; Wang N; Guo Q; Tao Y; Ma J
Curr Issues Mol Biol; 2023 Mar; 45(3):2013-2020. PubMed ID: 36975499
[TBL] [Abstract][Full Text] [Related]
7. ERα and ERβ Homodimers in the Same Cellular Context Regulate Distinct Transcriptomes and Functions.
Song D; He H; Indukuri R; Huang Z; Stepanauskaite L; Sinha I; Haldosén LA; Zhao C; Williams C
Front Endocrinol (Lausanne); 2022; 13():930227. PubMed ID: 35872983
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and pathological study on IgG4-related ophthalmic disease involving the lacrimal gland].
Li HQ; Lin JY; Zhao H
Zhonghua Yan Ke Za Zhi; 2019 Nov; 55(11):834-841. PubMed ID: 31715680
[No Abstract] [Full Text] [Related]
9. Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.
Cho MA; Lee MK; Nam KH; Chung WY; Park CS; Lee JH; Noh T; Yang WI; Rhee Y; Lim SK; Lee HC; Lee EJ
J Endocrinol; 2007 Nov; 195(2):255-63. PubMed ID: 17951536
[TBL] [Abstract][Full Text] [Related]
10. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.
Chang EC; Frasor J; Komm B; Katzenellenbogen BS
Endocrinology; 2006 Oct; 147(10):4831-42. PubMed ID: 16809442
[TBL] [Abstract][Full Text] [Related]
11. Expression of Androgen and Estrogen Receptors in the Human Lacrimal Gland.
Hat K; Planinić A; Ježek D; Kaštelan S
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982683
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomic analysis identifies gene networks regulated by estrogen receptor α (ERα) and ERβ that control distinct effects of different botanical estrogens.
Gong P; Madak-Erdogan Z; Li J; Cheng J; Greenlief CM; Helferich W; Katzenellenbogen JA; Katzenellenbogen BS
Nucl Recept Signal; 2014; 12():e001. PubMed ID: 25363786
[TBL] [Abstract][Full Text] [Related]
13. Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation.
Grober OM; Mutarelli M; Giurato G; Ravo M; Cicatiello L; De Filippo MR; Ferraro L; Nassa G; Papa MF; Paris O; Tarallo R; Luo S; Schroth GP; Benes V; Weisz A
BMC Genomics; 2011 Jan; 12():36. PubMed ID: 21235772
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ERbeta.
Monroe DG; Getz BJ; Johnsen SA; Riggs BL; Khosla S; Spelsberg TC
J Cell Biochem; 2003 Oct; 90(2):315-26. PubMed ID: 14505348
[TBL] [Abstract][Full Text] [Related]
15. Microarray analysis of altered gene expression in ERbeta-overexpressing HEK293 cells.
Zhao C; Putnik M; Gustafsson JA; Dahlman-Wright K
Endocrine; 2009 Oct; 36(2):224-32. PubMed ID: 19680825
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen.
Wu X; Subramaniam M; Grygo SB; Sun Z; Negron V; Lingle WL; Goetz MP; Ingle JN; Spelsberg TC; Hawse JR
Breast Cancer Res; 2011 Mar; 13(2):R27. PubMed ID: 21392396
[TBL] [Abstract][Full Text] [Related]
17. Profiling estrogen, progesterone, and androgen receptors in colorectal cancer in relation to gender, menopausal status, clinical stage, and tumour sidedness.
Refaat B; Aslam A; Idris S; Almalki AH; Alkhaldi MY; Asiri HA; Almaimani RA; Mujalli A; Minshawi F; Alamri SA; AlHussain MI; Baltow BA; Alqasmi MH; Basfar GT; Alosaimi OM; Muhayya IA
Front Endocrinol (Lausanne); 2023; 14():1187259. PubMed ID: 37206439
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptors alfa (ERalpha) and beta (ERbeta) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11.
Helguero LA; Faulds MH; Gustafsson JA; Haldosén LA
Oncogene; 2005 Oct; 24(44):6605-16. PubMed ID: 16007178
[TBL] [Abstract][Full Text] [Related]
19. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.
Williams C; Edvardsson K; Lewandowski SA; Ström A; Gustafsson JA
Oncogene; 2008 Feb; 27(7):1019-32. PubMed ID: 17700529
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
